Dubai, United Arab Emirates – Epinest, the French health software publisher and expert in optimizing hospital protocols and patient care pathways, will visit the UAE in February 2021 to meet health professionals and hospitals in order to introduce its latest advancements in the sector.

Since 2013, Epinest has brought together, trained and selected experts in three areas of expertise H.R.I.S solutions (consulting and integration), new technologies development & implementation and SmartHealth.

After years of Research and Development, with the same dedicated passion for combining  technology and improving people’s quality of life, Epinest launched its first eHealth EU certified products into  the market, leading to all of its solutions being recognized internationally by major healthcare establishments such as François Baclesse Hospital Center, the Cotentin Public Hospital Center, as well as strong partners in the field of public research; namely, the GREYC Laboratory of the French National Center for Scientific Research.

Some of the key developments that will be presented in Dubai next month include:

  • OPTIMA Onco, a software solution improving the patient journey while relieving the nursing staff and minimize losses at all levels by optimizing the entire patient care process. OPTIMA Onco benefits from an E.U. (C.E.) marking and is certified by the French Public High Authority of Healthcare.
  • Biotop Portal, the ideal solution to break down barriers between hospitals and private medical practitioners and clinics; it’s a unique interface allowing all nursing and medical staff involved in the patient journey and operating outside the patient’s hospital to quickly have access to their entire information files including, prescriptions, high-resolution medical images, blood test results..etc. The entire data record is available in real time and with very high security and interoperability requirements.
  • The MiDiPath project (Digital Microscopy in Pathological Anatomy and Cytology) which aims to develop new digital tools, providing pathologists with assistance (in the diagnosis and prognosis of serious pathologies) to the detection of rare elements applied to specific types of tumors, using artificial intelligence technology.

“Our mission is to support hospitals in the transformation and optimization of their processes, while having in mind both patient comfort, rationalization of medical time and better economic performance. Additionally, our long-term partnerships with esteemed healthcare organizations have triggering the advent of new modes of collaboration conducive to more innovation (IA, IoT, Patient-Centric, etc.) and to the co-construction of the health ecosystem of tomorrow”, expressed Mr. Elyes BEN MANSOUR, Co-Founder and Chief Executive Officer of Epinest. 

Epinest has been growing in global presence from France to Canada. Further to this launch in the UAE, it aims to establish presence across the region by 2023.

For more information, watch the video: https://www.youtube.com/watch?v=RtSZOhwHxus 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.